Dermalog Cream

Introduction

Dermalog Cream 0.1% is a potent topical corticosteroid used to reduce inflammation and itching in various dermatologic conditions. It is applied directly to the skin in the form of creams, ointments, or lotions and is typically prescribed for short-term management of severe inflammatory skin conditions.

Uses

Dermalog Cream 0.1% is used to treat a variety of inflammatory skin disorders, including:

Psoriasis
Atopic dermatitis
Contact dermatitis
Other inflammatory skin conditions where a potent anti-inflammatory agent is required.

It is generally used when other less potent topical steroids have failed to provide adequate relief.

Brand Name	Dermalog
Type	Cream
Weight	0.1%
Generic	Halcinonide
Manufacturer	Jayson Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Dermalog Cream 0.1% exerts its effects through binding to corticosteroid receptors within the cells, leading to decreased inflammation and immune response. This action reduces the production of inflammatory mediators, including prostaglandins and leukotrienes, thus alleviating symptoms such as redness, swelling, and itching.

How Long Does It Take to Work?

The onset of action for Dermalog Cream 0.1% can vary, but improvement in symptoms is generally observed within a few days of starting treatment. The full therapeutic effects may take several days to a couple of weeks, depending on the severity of the condition and individual response to the medication.

Absorption

Dermalog Cream 0.1% is absorbed through the skin upon topical application. Systemic absorption is minimal but can occur, especially if large areas of skin are treated or if occlusive dressings are used. The extent of systemic absorption can vary based on the condition of the skin and the vehicle used for the medication.

Route of Elimination

Dermalog Cream 0.1% is primarily metabolized in the liver. The metabolites are then excreted through the urine. The minimal systemic absorption typically leads to limited systemic metabolism and excretion.

Dosage

Adults: Halcinonide should be applied to the affected areas 2-3 times daily. In long term therapy or where lower strength preparation are required, use intermittently.

Children: Use minimal amount necessary for effective therapy. For effective treatment use the minimal amount, if necessary.

The dosage of Dermalog Cream 0.1% depends on the specific formulation and the condition being treated:

Topical application: Apply a thin layer to the affected area 2-3 times daily or as directed by a healthcare provider.

The frequency and amount of application should be adjusted based on the severity of the condition and the response to treatment.

Administration

To administer Dermalog Cream 0.1%:

Clean and dry the affected area before application.
Apply a thin layer of the medication to the affected area.
Gently rub the medication in until it is evenly distributed.
Wash hands thoroughly after application unless the hands are the area being treated.

Avoid occlusive dressings unless instructed by a healthcare provider.

Side Effects

Common side effects include:

Skin irritation, burning, or itching at the application site.
Dryness or peeling of the skin.
Increased sensitivity or erythema.

Long-term use or application to large areas may increase the risk of systemic side effects or skin thinning.

Toxicity

Toxicity is rare with proper use but may occur with overuse or prolonged application, particularly under occlusive dressings. Symptoms of toxicity may include skin thinning, striae, or systemic effects like adrenal suppression. Seek medical attention if any severe symptoms develop.

Precautions

Precautions include:

Use with caution in patients with a history of skin infections or systemic diseases.
Monitor for signs of local or systemic adverse effects, especially with long-term use.
Avoid contact with eyes, mucous membranes, and open wounds.

Regular follow-up with a healthcare provider is advised to assess the effectiveness and safety of the treatment.

Interaction

Topical corticosteroids like Dermalog Cream 0.1% may interact with other topical medications applied to the same area. Ensure to inform the healthcare provider of all concurrent topical treatments to avoid potential interactions.

Disease Interaction

Use Dermalog Cream 0.1% with caution in patients with:

Skin infections (bacterial, fungal, or viral).
Systemic conditions that might be exacerbated by corticosteroids, such as diabetes or hypertension.

Such conditions may require adjustment of treatment or additional precautions.

Drug Interaction

Drug interactions are minimal with topical application. However, concurrent use with other corticosteroids or drugs that affect skin absorption or metabolism may require careful monitoring.

Food Interactions

There are no specific food interactions reported with Dermalog Cream 0.1%. Maintaining a balanced diet supports overall health and can be beneficial during treatment.

Pregnancy Use

Dermalog Cream 0.1% should be used during pregnancy only if clearly needed and prescribed by a healthcare provider. The potential risks and benefits must be weighed, as corticosteroids can affect fetal development.

Lactation Use

Dermalog Cream 0.1% is generally considered safe for use during lactation when applied topically. However, avoid application to the breasts to prevent accidental ingestion by the infant. Consult a healthcare provider for personalized advice.

Acute Overdose

Acute overdose is unlikely with topical application. In case of accidental ingestion or significant overuse, seek medical attention immediately. Symptoms of overdose may include severe skin reactions or systemic effects.

Contraindication

Contraindications include:

Hypersensitivity to Dermalog Cream 0.1% or any other ingredients in the formulation.
Active untreated infections of the skin.

Avoid use in these conditions to prevent exacerbation of the problem or adverse reactions.

Use Direction

Follow the prescribed dosage and application instructions carefully. Avoid using more than the recommended amount and do not apply to large areas of the body or under occlusive dressings unless directed by a healthcare provider.

Storage Conditions

Store Dermalog Cream 0.1% at room temperature, away from direct light and moisture. Keep the medication out of reach of children and ensure the container is properly sealed to maintain efficacy.

Volume of Distribution

The volume of distribution for Dermalog Cream 0.1% is not typically measured in topical applications. The medication acts locally at the site of application with minimal systemic distribution.

Half Life

The half-life of Dermalog Cream 0.1% in topical applications is not well-defined. The drug’s effects persist locally at the application site, and systemic half-life data may not be directly applicable.

Clearance

Dermalog Cream 0.1% is cleared primarily through hepatic metabolism and renal excretion. The minimal systemic absorption associated with topical application generally results in limited systemic clearance.

See in details version Dermalog Cream 0.1% also Dermalog Cream 0.1% in bangla